Novel Medical Implants Revolutionize the U.S. Implantable Medical Devices Market

 

Increasing prevalence of chronic disorders that require medical implants is expected to propel growth of the U.S. implantable medical devices market. According to the American Heart Association 2019 Heart Disease and Stroke Statistics, around 5.3 million people in the U.S. suffer from atrial fibrillation and around 795,000 people have a new or recurrent stroke annually.

Novel implantable medical devices have revolutionized the U.S. implantable medical devices market. These amazing devices can be surgically implanted anywhere in the body with great ease and the person can regain his or her health with increased mobility. Implantable high-tech devices, including implantable cardiac pacemakers, implantable insulin pumps, implantable vascular pumps, implantable cardiac scaffolds, laser-assisted veneers and other accessories, offer new quality of life to patients with various diseases.

The geriatric population more than often requires artificial hips, knees and ankles. According to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.  Thus, increasing geriatric population is also expected to aid in growth of the U.S. implantable medical devices market. Moreover, implantable medical devices like artificial veins and other accessories are suitable for those who have had heart surgery.

Due to their life-changing benefits, medical implants have gained tremendous popularity across the U.S., which is expected to aid in growth of the U.S. implantable medical devices market.  Implantable medical devices are usually custom-made. The material used in the manufacturing process is chosen after checking the suitability of the material for the particular implant method. They are fitted into the patient's body through surgical means. They are placed above the muscle layer or behind the bone for easier implantation into the body.

The U.S. implantable medical devices market is witnessing increasing adoption of 3D printing in developing implantable medical devices. For instance, in April 2020, SLM Solutions, a Germany-based metal 3D printing company, entered into a strategic partnership with Canwell Medical, a medical device manufacturer based in China, for the development of 3D printed surgical implants.

Implantable medical devices are made up of silicon and are very flexible. These implantable medical devices are often used for the treatment of breast cancer. According to the American Cancer Society, in 2020, around 276,480 new cases of invasive breast cancer will be diagnosed in women and the disease will lead to around 42,170 deaths, in the U.S. Thus, high prevalence of breast cancer is expected to aid in growth of the U.S. implantable medical devices market.

Bioresorbable medical devices are made up of either biological materials and are fit into the human body through the use of incision methods. There is a risk factor for the patient when it comes to the bioresorbable medical devices but the risk factor is greatly reduced when compared to the other implantable medical devices. In addition to this, bioresorbable materials are also easy to maintain and clean after use, which in turn has increased their demand in the U.S. implantable medical devices market.